December 13, 2021
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the sample preparation workflow, from DNA sample input [...]
December 13, 2021
Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners MARLBOROUGH, Mass. -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced a collaboration to advance the discovery and validation of novel predictive [...]
Accellix Raises $10 Million From BroadOak Capital Partners
December 13, 2021
Accellix will use the investment to expand its commercial resources and infrastructure in support of its cell therapy customers SAN JOSE, Calif. & BETHESDA, Md. -- Accellix Inc., which provides quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use by cell therapy companies on the manufacturing floor and at [...]
December 13, 2021
Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces the launch of its new RapidScan ST5-W lateral flow reader, specifically designed for field and in-process testing applications requiring qualitative to semi-quantitative test results. This portable instrument is a highly flexible, easy to use and accurate imaging platform used for lateral flow assay [...]
Oncomine Myeloid Assay GX v2 Provides Comprehensive, Rapid Molecular Profiling of Myeloid Samples
December 10, 2021
CARLSBAD, Calif. Overview: The Ion Torrent Oncomine Myeloid Assay GX v2* from Thermo Fisher Scientific is the first next-generation sequencing (NGS) assay that allows researchers to gather comprehensive mutational results from myeloid samples in a single day using the Ion Torrent Genexus System.* As the list of myeloid biomarkers continues to grow, rapid and streamlined solutions [...]
BigOmics Raises $1.85M to Revolutionize Omics Data Analytics
December 10, 2021
Bellinzona, Switzerland – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will allow the company to expand its team and to commercialize its governed self-service analytics (GSSA) platforms to empower life scientists. BigOmics raised $1.42 million on the first closing of [...]
December 10, 2021
New Electronic Balance Models: AP225W-AD (with 0.01 mg minimum display value) (left) and AP324W-AD (with 0.1 mg minimum display value) (right) Shimadzu Corporation released six new models in its AP-AD series of analytical balances simultaneously in Japan and other countries. The new AP-AD series models not only offer excellent basic performance, such as fast weighing [...]
New Sample Preparation Solution Simplifies Food Safety Testing
December 9, 2021
The Thermo Scientific QuEChERS portfolio delivers robust, sensitive quantitation in compliance with global regulatory requirements LANGERWEHE, Germany – Food industry, government and contract testing laboratories performing food safety analysis can now benefit from a new portfolio that offers cost-effective, robust Solid-Phase Extraction (SPE) solutions to support food safety workflows and meet regulatory requirements across Europe, [...]
HTG Announces Major Sales Milestone for HTG Transcriptome Panel
December 9, 2021
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1 million of revenue recognized from sales of its HTG Transcriptome Panel (HTP) as of November 30, 2021. HTP was launched with commercial availability in the United [...]
Illumina Supports Norway’s Pioneering Precision Medicine Study
December 9, 2021
Study to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing. The study will also evaluate [...]
